291 related articles for article (PubMed ID: 35963821)
1. Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020.
Maeda H; Gopal Dhoubhadel B; Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
Vaccine; 2022 Sep; 40(37):5504-5512. PubMed ID: 35963821
[TBL] [Abstract][Full Text] [Related]
2. Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States.
Huang L; Wasserman M; Grant L; Farkouh R; Snow V; Arguedas A; Chilson E; Sato R; Perdrizet J
Vaccine; 2022 Aug; 40(33):4700-4708. PubMed ID: 35753839
[TBL] [Abstract][Full Text] [Related]
3. Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs.
Horn M; Theilacker C; Sprenger R; von Eiff C; Mahar E; Schiffner-Rohe J; Pletz MW; van der Linden M; Scholz M
PLoS One; 2023; 18(2):e0281261. PubMed ID: 36791091
[TBL] [Abstract][Full Text] [Related]
4. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
[TBL] [Abstract][Full Text] [Related]
5. Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies.
Grant LR; Slack MPE; Theilacker C; Vojicic J; Dion S; Reinert RR; Jodar L; Gessner BD
Vaccine; 2023 Aug; 41(38):5662-5669. PubMed ID: 37544825
[TBL] [Abstract][Full Text] [Related]
6. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
Vaccine; 2019 May; 37(20):2687-2693. PubMed ID: 30975569
[TBL] [Abstract][Full Text] [Related]
7. Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines.
Dion SB; Major M; Gabriela Grajales A; Nepal RM; Cane A; Gessner B; Vojicic J; Suaya JA
Vaccine; 2021 May; 39(22):3007-3017. PubMed ID: 33824041
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
Grant LR; Slack MPE; Theilacker C; Vojicic J; Dion S; Reinert RR; Jodar L; Gessner BD
Clin Infect Dis; 2023 Feb; 76(3):e1062-e1070. PubMed ID: 35789262
[TBL] [Abstract][Full Text] [Related]
9. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
[TBL] [Abstract][Full Text] [Related]
10. Spread of multidrug resistance in non-PCV13/PCV20 serotypes of Streptococcus pneumoniae: A cross-sectional study ten years after the introduction of pneumococcal conjugate vaccine in Japan.
Kawaguchiya M; Urushibara N; Aung MS; Ohashi N; Takamatsu R; Tsutida S; Ito M; Kobayashi N
J Microbiol Immunol Infect; 2023 Dec; 56(6):1288-1292. PubMed ID: 37517964
[TBL] [Abstract][Full Text] [Related]
11. Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017.
Noguchi S; Yatera K; Akata K; Chang B; Ikegami H; Hata R; Yamasaki K; Kawanami T; Mukae H
J Infect Chemother; 2019 Nov; 25(11):925-929. PubMed ID: 31350184
[TBL] [Abstract][Full Text] [Related]
12. Strategies for pneumococcal vaccination in older adults in the coming era.
Nakashima K; Fukushima W
Hum Vaccin Immunother; 2024 Dec; 20(1):2328963. PubMed ID: 38517265
[TBL] [Abstract][Full Text] [Related]
13. Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia.
Grant LR; Begier E; Theilacker C; Barry R; Hall-Murray C; Yan Q; Pope V; Pride MW; Jodar L; Gessner BD
J Infect Dis; 2024 Jan; 229(1):282-293. PubMed ID: 37665210
[TBL] [Abstract][Full Text] [Related]
14. 20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.
Shirley M
Drugs; 2022 Jun; 82(9):989-999. PubMed ID: 35793027
[TBL] [Abstract][Full Text] [Related]
15. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
[TBL] [Abstract][Full Text] [Related]
16. The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015.
Akata K; Chang B; Yatera K; Kawanami T; Naito K; Noguchi S; Kido T; Mukae H
J Infect Chemother; 2017 May; 23(5):301-306. PubMed ID: 28262532
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal serotype evolution in Western Europe.
Tin Tin Htar M; Christopoulou D; Schmitt HJ
BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
[TBL] [Abstract][Full Text] [Related]
18. Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era.
de Miguel S; Domenech M; González-Camacho F; Sempere J; Vicioso D; Sanz JC; Comas LG; Ardanuy C; Fenoll A; Yuste J
Clin Infect Dis; 2021 Dec; 73(11):e3778-e3787. PubMed ID: 32990303
[TBL] [Abstract][Full Text] [Related]
19. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
